Stay updated on AMG 562 in Lymphoma: Safety, PK, Efficacy Clinical Trial
Sign up to get notified when there's something new on the AMG 562 in Lymphoma: Safety, PK, Efficacy Clinical Trial page.

Latest updates to the AMG 562 in Lymphoma: Safety, PK, Efficacy Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe NIH notice about the transition from “Artificial Intelligence” to “Super Intelligence,” including its update links, is no longer displayed. The study page still shows a 403 Forbidden error.SummaryDifference1%

- Check19 days agoChange DetectedThe footer revision identifier changed from v3.7.2 to v3.8.0; the page continues to show a 403 Forbidden error rather than the study record.SummaryDifference0.2%

- Check26 days agoChange DetectedA banner announces NIH website updates and says agencies are transitioning from the term “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check33 days agoChange DetectedThe site footer revision identifier changed from v3.7.1 to v3.7.2. The page still displays a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check40 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check60 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the study details with an error page and preventing access to the record and its related information.SummaryDifference20%

Stay in the know with updates to AMG 562 in Lymphoma: Safety, PK, Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AMG 562 in Lymphoma: Safety, PK, Efficacy Clinical Trial page.